Incyte Plays Down Ruxolitinib Cream Label Worries Following Atopic Dermatitis Approval

Opzelura Is First Topical JAK Inhibitor Approved In US

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.